SVAS BIOSANA risk profile
32 Normal where most of the sector sits
Measured 1 September 2026 from SVS.MI's filed statements. Recomputed nightly.
32 (Normal), driven by Cash conversion at 76, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 44 | Elevated | Stable | One-year price volatility — 27.9% |
| Operating pressure | 39 | Normal | Worsening | Costs outgrowing revenue — -0.7 percentage points |
| Cash conversion | 76 | Stretched | Worsening | Capital spending against operating cash — 1.89x |
| Leverage and coverage | 42 | Elevated | Worsening | Interest cover — 4.62x |
| Competitive position | 11 | Contained | Stable | Revenue-growth gap against peers — +27.2 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.